Cronos Group Inc. reports developments for a global cannabis and cannabinoid company focused on consumer goods, cannabis research, technology and product development. Its brand portfolio includes Spinach®, PEACE NATURALS®, LIT® and Lord Jones®, with news often centered on product innovation across Canadian cannabis formats such as pre-rolls and vapes.
Recurring Cronos updates also cover operating and financial results, earnings conference calls, annual shareholder meetings, proxy and governance matters, capital-structure disclosures and public-company presentations. The company’s disclosures connect brand launches and R&D-driven product development with the financial and governance reporting of a Nasdaq- and TSX-listed cannabis issuer.
Cronos Group Inc. has launched its medical brand PEACE NATURALS™ in Israeli pharmacies through Cronos Israel. The cultivation and production occur at their facility in Kibbutz Gan Shmuel, which complies with local certifications. The brand, established in Canada in 2013, aims to provide high-quality products, importing dried flower and plant cuttings from Canada. With a growing medical cannabis market in Israel, Cronos sees significant opportunities for expansion. The company emphasizes its commitment to high standards and improving patient access to medical cannabis.
Summary not available.
Cronos Group, a global cannabinoid company, announced that its Executive Chairman, Mike Gorenstein, will speak at the CIBC 19th Annual Eastern Institutional Investor Conference on September 17, 2020, at 2:40 p.m. EDT. The conference will be accessible via a webcast on the Company's investor website. Cronos Group is focused on advancing cannabis research and developing an iconic brand portfolio, including wellness and adult-use brands. Their portfolio includes PEACE NATURALS™, COVE™, Spinach™, Lord Jones™, and PEACE+™.
Cronos Group has appointed Kurt Schmidt as President and CEO, effective September 9, 2020. Schmidt brings over 30 years of consumer packaged goods experience, having held key roles at Blue Buffalo and Nestlé. Mike Gorenstein transitions to Executive Chairman after serving as CEO since 2016. Both leaders aim to drive growth and leverage Cronos' strengths in cannabinoid innovation and brand development. The leadership change is expected to enhance company performance and accelerate its mission to create a strong brand portfolio and advanced cannabis research.